- Home
- TOUR vs COEP Comparison
TOUR vs COEP Comparison
Compare TOUR & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOUR | COEP |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.0M | 100.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TOUR | COEP |
|---|---|---|
| Price | $0.58 | $11.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 91.1K | 59.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 6.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.27 | N/A |
| Revenue Next Year | $10.18 | N/A |
| P/E Ratio | $90.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.58 | $6.26 |
| 52 Week High | $1.17 | $21.41 |
Technical Indicators
Market Signals| Indicator | TOUR | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 33.79 | 40.37 |
| Support Level | $0.62 | $11.38 |
| Resistance Level | $0.65 | $12.40 |
| Average True Range (ATR) | 0.02 | 1.19 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 29.79 | 23.85 |
Price Performance
Historical ComparisonAbout TOUR Tuniu Corporation
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.